insulin glargine

Advertisement

cGxPJobs Banner

Biocon Biologics Expands Insulin Glargine Access in U.S.

BRIDGEWATER, N.J., and BENGALURU, India – October 16, 2025: Biocon Biologics Ltd., a global leader in biosimilars, has expanded...

By cGxPwire Editor
October 16, 2025

Read More

Bio-Pharma Pharma

Lilly’s Oral GLP-1 Orforglipron Delivers Strong Phase 3 Results in Type 2 Diabetes

INDIANAPOLIS, Oct. 15, 2025 — Eli Lilly and Company (NYSE: LLY) announced positive topline results from two pivotal Phase...

By cGxPwire Editor
October 15, 2025

Read More

Advertisement

cGxPJobs

Directory